Raymond James Financial »

Allogene Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 679k 2.08
2025-06-30 $50 45 1.13

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p Mcp Etf (IJH)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics